Medical News

RSS

FDA provides guidance on Restanza clinical program in treatment of CABP

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.

11 Mar 2010

Pro-Pharmaceuticals announces closing of $335,000 tranche of private placement

Pro-Pharmaceuticals, Inc., today announced that it has closed a $335,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $5.1 million.

11 Mar 2010

Smith & Nephew launches TWINFIX Ultra PK Suture Anchor for rotator cuff repair

Smith & Nephew's Endoscopy Division today announced the introduction of the TWINFIX™ Ultra PK Suture Anchor, a new anchor to address wide variation in bone density and tissue quality for rotator cuff repair in the shoulder. The device is currently being featured at Smith & Nephew Endoscopy's booth at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans.

11 Mar 2010

Peregrine Pharmaceuticals' third-quarter fiscal 2010 total revenues up 45%

Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and serious viral infections, today announced financial results for the third quarter of fiscal year (FY) 2010 ended January 31, 2010. The company also provided an update on its clinical programs and corporate developments.

From Thermo Fisher Scientific Inc. 11 Mar 2010

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).

11 Mar 2010

Advanced Life Sciences Holdings reports decrease in net loss for full-year 2009

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.

11 Mar 2010

Florida Hospital Patient Protection Act of 2010 filed in state legislature

National Nurses Organizing Committee-Florida and National Nurses United today announce that the Florida Hospital Patient Protection Act of 2010 has been filed in the state legislature by authors Rep. Oscar Braynon and Sen. Tony Hill and will be known as HB 1283 and S 2316.

11 Mar 2010

Decade of Action for Road Safety seeks to halt increasing trends in road traffic deaths, injuries worldwide

WHO welcomes the proclamation by the UN General Assembly of the first "Decade of Action for Road Safety 2011-2020" which seeks to halt the increasing trends in road traffic deaths and injuries worldwide.

11 Mar 2010

Legalising cannabis: School children debate

Should cannabis be legalised? This thorny political issue will be debated by teams of school children in a national competition designed to challenge the pupil's scientific knowledge. The event is part of the Festival of Social Science organised by the Economic and Social Research Council (ESRC) and will be staged at the Royal Pharmaceutical Society of Great Britain.

11 Mar 2010

Private sector auditors to root out fraud in Medicare and Medicaid: CAGW lauds decision

The nation’s premier taxpayer watchdog group, Citizens Against Government Waste (CAGW), today applauded President Obama for announcing that he will use private sector auditors to root out fraud in the country’s two massive government-run healthcare plans, Medicare and Medicaid. The practice of using private sector auditors to identify and recover improper overpayments to healthcare contractors and providers, technically called recovery audit contractors (RACs), has been a staple in the private sector for many years.

11 Mar 2010

Helix BioMedix enters into distribution agreement with RubyDerm Bio

Helix BioMedix, Inc., a developer of bioactive peptides, announced that the Company entered into an agreement with RubyDerm Bio, Inc. under which RubyDerm will assume responsibility, on an exclusive basis, for the distribution of certain of Helix BioMedix’s branded prestige skin care products to spas, beauty stores, hospitals, clinics, physicians, and consumers in South Korea, China and Japan.

11 Mar 2010

TTI granted exclusive worldwide rights to commercialize two immunology programs

Trillium Therapeutics Inc., a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into two definitive license agreements with University Health Network and The Hospital for Sick Children in Toronto, Ontario, granting Trillium exclusive worldwide rights to commercialize two immunology programs in the areas of hematopoietic stem cell transplantation and cancer.

11 Mar 2010

NeoMed invests in CytoCore

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that NeoMed has made an investment in CytoCore Inc.

11 Mar 2010

Illumina sequences DNA of American actress Glenn Close

Illumina, Inc. today announced that it has sequenced the DNA of American actress Glenn Close, the first publicly named female to have her DNA sequenced to full coverage.

From Illumina, Inc. 11 Mar 2010

Orchid Cellmark reports 21% increase in total revenues for fourth-quarter 2009

Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.

11 Mar 2010

Response Biomedical's 2009 total revenues up 69%

Response Biomedical Corporation reported that it recorded total revenues of $9,946,269, an increase of 69% compared to $5,876,337 in 2008. Clinical products revenue for the year ended December 31, 2009 increased 85% to $6,828,651 compared to $3,683,706 in 2008.

11 Mar 2010

USPTO issues patent related to Seattle Genetics' ADC technology

Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics’ ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.

11 Mar 2010

MEDNAX acquires Maryland Perinatal Associates

MEDNAX, Inc., today announced the acquisition of Maryland Perinatal Associates, PC, a group of four maternal-fetal medicine physicians based in Rockville, Maryland.

11 Mar 2010

Evaluating true toxicity of drugs: Changes in collecting and reporting adverse symptom information needed

A Perspective piece in the New England Journal of Medicine calls for change in the way researchers and pharmaceutical companies collect and report adverse symptom information in clinical trials submitted to the Food and Drug Administration (FDA), and how the FDA represents this information on drug labels.

11 Mar 2010

First Edition: March 11, 2010

Today's headlines offer details of President Obama's continued full-court press on health reform with an appearance in Missouri. Meanwhile, work to move the bill toward a vote continues on Capitol Hill.

11 Mar 2010